| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.983 | 0.001 | 0.986 | Aldehyde oxidase inhibitor | 0.986 0.001 DB00977 0.986 0.001 DBMET00457 | DBMET00457 | |
| 0.846 | 0.002 | 0.939 | Estrogen receptor alpha antagonist | 0.939 0.001 DB00977 0.939 0.001 DBMET00457 | DBMET00457 | |
| 0.781 | 0.001 | 0.787 | Progesterone antagonist | 0.787 0.001 DB00977 0.787 0.001 DBMET00457 | DBMET00457 | |
| 0.781 | 0.002 | 0.872 | Estrogen agonist | 0.872 0.002 DB00977 0.872 0.002 DBMET00457 | DBMET00457 | |
| 0.781 | 0.002 | 0.883 | Androgen antagonist | 0.883 0.002 DB00977 0.883 0.002 DBMET00457 | DBMET00457 | |
| 0.746 | 0.004 | 0.746 | Hypoxia-inducible factor 1 alpha inhibitor | 0.737 0.004 DB00977 0.737 0.004 DBMET00457 | ||
| 0.75 | 0.018 | 0.75 | Caspase 9 stimulant | 0.681 0.026 DB00977 0.681 0.026 DBMET00457 | ||
| 0.743 | 0.017 | 0.767 | Transcription factor NF kappa B inhibitor | 0.767 0.015 DB00977 0.767 0.015 DBMET00457 | DBMET00457 | |
| 0.703 | 0.002 | 0.758 | Aromatase inhibitor | 0.758 0.002 DB00977 0.758 0.002 DBMET00457 | DBMET00457 | |
| 0.709 | 0.029 | 0.758 | Antiinflammatory | 0.758 0.021 DB00977 0.758 0.021 DBMET00457 | DBMET00457 | |
| 0.646 | 0.003 | 0.799 | Estrogen antagonist | 0.799 0.003 DB00977 0.799 0.003 DBMET00457 | DBMET00457 | |
| 0.628 | 0.002 | 0.653 | Lipocortins synthesis antagonist | 0.653 0.002 DB00977 0.653 0.002 DBMET00457 | DBMET00457 | |
| 0.613 | 0.002 | 0.811 | Androgen agonist | 0.811 0.001 DB00977 0.811 0.001 DBMET00457 | DBMET00457 | |
| 0.646 | 0.04 | 0.67 | Apoptosis agonist | 0.67 0.036 DB00977 0.67 0.036 DBMET00457 | DBMET00457 | |
| 0.509 | 0.002 | 0.592 | Estrogen receptor alpha agonist | 0.592 0.002 DB00977 0.592 0.002 DBMET00457 | DBMET00457 | |
| 0.51 | 0.007 | 0.521 | Anesthetic general | 0.521 0.007 DB00977 0.521 0.007 DBMET00457 | DBMET00457 | |
| 0.501 | 0.002 | 0.589 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.589 0.002 DB00977 0.589 0.002 DBMET00457 | DBMET00457 | |
| 0.498 | 0.002 | 0.594 | Glucocorticoid antagonist | 0.594 0.002 DB00977 0.594 0.002 DBMET00457 | DBMET00457 | |
| 0.497 | 0.004 | 0.512 | Sodium/bile acid cotransporter inhibitor | 0.512 0.003 DB00977 0.512 0.003 DBMET00457 | DBMET00457 | |
| 0.495 | 0.002 | 0.619 | Estradiol 17 beta-dehydrogenase inhibitor | 0.619 0.002 DB00977 0.619 0.002 DBMET00457 | DBMET00457 | |
| 0.46 | 0.004 | 0.637 | Estrogen receptor beta antagonist | 0.637 0.003 DB00977 0.637 0.003 DBMET00457 | DBMET00457 | |
| 0.483 | 0.038 | 0.502 | Immunosuppressant | 0.502 0.032 DB00977 0.502 0.032 DBMET00457 | DBMET00457 | |
| 0.372 | 0.001 | 0.672 | Anabolic | 0.672 0.001 DB00977 0.672 0.001 DBMET00457 | DBMET00457 | |
| 0.397 | 0.029 | 0.399 | DNA damaging | 0.399 0.029 DB00977 0.399 0.029 DBMET00457 | DBMET00457 | |
| 0.359 | 0.003 | 0.527 | Estrogen receptor beta agonist | 0.527 0.003 DB00977 0.527 0.003 DBMET00457 | DBMET00457 | |
| 0.356 | 0.002 | 0.44 | Prolactin inhibitor | 0.44 0.002 DB00977 0.44 0.002 DBMET00457 | DBMET00457 | |
| 0.345 | 0.001 | 0.415 | Progesterone agonist | 0.415 0.001 DB00977 0.415 0.001 DBMET00457 | DBMET00457 | |
| 0.354 | 0.016 | 0.468 | Diuretic | 0.468 0.009 DB00977 0.468 0.009 DBMET00457 | DBMET00457 | |
| 0.337 | 0.004 | 0.392 | Mineralocorticoid receptor antagonist | 0.392 0.003 DB00977 0.392 0.003 DBMET00457 | DBMET00457 | |
| 0.33 | 0.003 | 0.332 | Aldosterone antagonist | 0.332 0.003 DB00977 0.332 0.003 DBMET00457 | DBMET00457 | |
| 0.321 | 0.016 | 0.378 | Lipid peroxidase inhibitor | 0.378 0.011 DB00977 0.378 0.011 DBMET00457 | DBMET00457 | |
| 0.303 | 0.002 | 0.379 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.379 0.002 DB00977 0.379 0.002 DBMET00457 | DBMET00457 | |
| 0.328 | 0.035 | 0.359 | Nitric oxide antagonist | 0.359 0.03 DB00977 0.359 0.03 DBMET00457 | DBMET00457 | |
| 0.284 | 0.004 | 0.339 | Keratolytic | 0.339 0.004 DB00977 0.339 0.004 DBMET00457 | DBMET00457 | |
| 0.295 | 0.019 | 0.371 | Neurotrophic factor enhancer | 0.371 0.007 DB00977 0.371 0.007 DBMET00457 | DBMET00457 | |
| 0.273 | 0.003 | 0.278 | Arachidonic acid antagonist | 0.278 0.003 DB00977 0.278 0.003 DBMET00457 | DBMET00457 | |
| 0.337 | 0.07 | 0.354 | Cholesterol antagonist | 0.354 0.063 DB00977 0.354 0.063 DBMET00457 | DBMET00457 | |
| 0.293 | 0.03 | 0.293 | Non-steroidal antiinflammatory agent | 0.262 0.038 DB00977 0.262 0.038 DBMET00457 | ||
| 0.282 | 0.021 | 0.366 | NOS3 expression enhancer | 0.366 0.01 DB00977 0.366 0.01 DBMET00457 | DBMET00457 | |
| 0.28 | 0.023 | 0.305 | Interferon gamma antagonist | 0.305 0.019 DB00977 0.305 0.019 DBMET00457 | DBMET00457 | |
| 0.268 | 0.022 | 0.311 | Bone formation stimulant | 0.311 0.016 DB00977 0.311 0.016 DBMET00457 | DBMET00457 | |
| 0.264 | 0.022 | 0.315 | Monophenol monooxygenase inhibitor | 0.315 0.016 DB00977 0.315 0.016 DBMET00457 | DBMET00457 | |
| 0.31 | 0.074 | 0.31 | Caspase 3 stimulant | 0.284 0.087 DB00977 0.284 0.087 DBMET00457 | ||
| 0.268 | 0.036 | 0.268 | P-glycoprotein inhibitor | 0.233 0.047 DB00977 0.233 0.047 DBMET00457 | ||
| 0.23 | 0.004 | 0.284 | 5-Alpha-reductase inhibitor | 0.284 0.003 DB00977 0.284 0.003 DBMET00457 | DBMET00457 | |
| 0.249 | 0.025 | 0.295 | Antipruritic | 0.295 0.015 DB00977 0.295 0.015 DBMET00457 | DBMET00457 | |
| 0.244 | 0.026 | 0.244 | Tubulin antagonist | 0.17 0.049 DB00977 0.17 0.049 DBMET00457 | ||
| 0.219 | 0.014 | 0.219 | Alpha 2c adrenoreceptor antagonist | 0.196 0.019 DB00977 0.196 0.019 DBMET00457 | ||
| 0.247 | 0.044 | 0.258 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.258 0.039 DB00977 0.258 0.039 DBMET00457 | DBMET00457 | |
| 0.194 | 0.002 | 0.213 | Estrone sulfatase inhibitor | 0.213 0.002 DB00977 0.213 0.002 DBMET00457 | DBMET00457 | |
| 0.247 | 0.068 | 0.293 | DNA synthesis inhibitor | 0.293 0.046 DB00977 0.293 0.046 DBMET00457 | DBMET00457 | |
| 0.256 | 0.08 | 0.308 | Antioxidant | 0.308 0.059 DB00977 0.308 0.059 DBMET00457 | DBMET00457 | |
| 0.202 | 0.026 | 0.215 | Cholesterol synthesis inhibitor | 0.215 0.023 DB00977 0.215 0.023 DBMET00457 | DBMET00457 | |
| 0.18 | 0.009 | 0.18 | Beta tubulin antagonist | 0.15 0.012 DB00977 0.15 0.012 DBMET00457 | ||
| 0.222 | 0.053 | 0.238 | Hepatoprotectant | 0.238 0.047 DB00977 0.238 0.047 DBMET00457 | DBMET00457 | |
| 0.207 | 0.039 | 0.259 | Acetylcholine M1 receptor antagonist | 0.259 0.023 DB00977 0.259 0.023 DBMET00457 | DBMET00457 | |
| 0.173 | 0.008 | 0.173 | Alpha tubulin antagonist | 0.155 0.009 DB00977 0.155 0.009 DBMET00457 | ||
| 0.167 | 0.004 | 0.19 | RNA-directed RNA polymerase stimulant | 0.19 0.003 DB00977 0.19 0.003 DBMET00457 | DBMET00457 | |
| 0.276 | 0.118 | 0.276 | Calcium channel activator | 0.223 0.181 DB00977 0.223 0.181 DBMET00457 | ||
| 0.174 | 0.027 | 0.174 | Microtubule formation inhibitor | 0.149 0.038 DB00977 0.149 0.038 DBMET00457 | ||
| 0.151 | 0.005 | 0.25 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.25 0.003 DB00977 0.25 0.003 DBMET00457 | DBMET00457 | |
| 0.15 | 0.007 | 0.159 | Glycine receptor agonist | 0.159 0.006 DB00977 0.159 0.006 DBMET00457 | DBMET00457 | |
| 0.166 | 0.023 | 0.179 | Antineoplastic alkaloid | 0.179 0.02 DB00977 0.179 0.02 DBMET00457 | DBMET00457 | |
| 0.169 | 0.027 | 0.182 | Pregnane X receptor agonist | 0.182 0.017 DB00977 0.182 0.017 DBMET00457 | DBMET00457 | |
| 0.179 | 0.038 | 0.23 | Cholinergic antagonist | 0.23 0.025 DB00977 0.23 0.025 DBMET00457 | DBMET00457 | |
| 0.281 | 0.143 | 0.32 | 15-Lipoxygenase inhibitor | 0.32 0.118 DB00977 0.32 0.118 DBMET00457 | DBMET00457 | |
| 0.175 | 0.038 | 0.226 | Acetylcholine antagonist | 0.226 0.025 DB00977 0.226 0.025 DBMET00457 | DBMET00457 | |
| 0.185 | 0.051 | 0.196 | Interleukin 6 antagonist | 0.196 0.043 DB00977 0.196 0.043 DBMET00457 | DBMET00457 | |
| 0.152 | 0.02 | 0.169 | Acetylcholine nicotinic antagonist | 0.169 0.016 DB00977 0.169 0.016 DBMET00457 | DBMET00457 | |
| 0.165 | 0.038 | 0.195 | Farnesoid X receptor antagonist | 0.195 0.023 DB00977 0.195 0.023 DBMET00457 | DBMET00457 | |
| 0.127 | 0.001 | 0.127 | Progesterone receptor A antagonist | 0.106 0.001 DB00977 0.106 0.001 DBMET00457 | ||
| 0.134 | 0.011 | 0.146 | Adrenaline uptake inhibitor | 0.146 0.01 DB00977 0.146 0.01 DBMET00457 | DBMET00457 | |
| 0.123 | 0.003 | 0.129 | Lipocortins synthesis agonist | 0.129 0.003 DB00977 0.129 0.003 DBMET00457 | DBMET00457 | |
| 0.16 | 0.042 | 0.173 | Alkylator | 0.173 0.036 DB00977 0.173 0.036 DBMET00457 | DBMET00457 | |
| 0.172 | 0.057 | 0.175 | Melanin inhibitor | 0.175 0.055 DB00977 0.175 0.055 DBMET00457 | DBMET00457 | |
| 0.125 | 0.015 | 0.143 | Glycine receptor antagonist | 0.143 0.009 DB00977 0.143 0.009 DBMET00457 | DBMET00457 | |
| 0.12 | 0.01 | 0.135 | Estrogen-related receptor beta agonist | 0.135 0.005 DB00977 0.135 0.005 DBMET00457 | DBMET00457 | |
| 0.102 | 0.003 | 0.126 | Glucocorticoid agonist | 0.126 0.002 DB00977 0.126 0.002 DBMET00457 | DBMET00457 | |
| 0.238 | 0.14 | 0.258 | Apoptosis antagonist | 0.258 0.12 DB00977 0.258 0.12 DBMET00457 | DBMET00457 | |
| 0.134 | 0.046 | 0.179 | Interleukin 8 antagonist | 0.179 0.019 DB00977 0.179 0.019 DBMET00457 | DBMET00457 | |
| 0.114 | 0.028 | 0.128 | Macrophage migration inhibitory factor inhibitor | 0.128 0.023 DB00977 0.128 0.023 DBMET00457 | DBMET00457 | |
| 0.105 | 0.027 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 DB00977 0.115 0.019 DBMET00457 | DBMET00457 | |
| 0.173 | 0.097 | 0.184 | Psychostimulant | 0.184 0.09 DB00977 0.184 0.09 DBMET00457 | DBMET00457 | |
| 0.154 | 0.083 | 0.154 | Sigma receptor agonist | 0.141 0.092 DB00977 0.141 0.092 DBMET00457 | ||
| 0.123 | 0.054 | 0.126 | GABA receptor agonist | 0.126 0.052 DB00977 0.126 0.052 DBMET00457 | DBMET00457 | |
| 0.096 | 0.028 | 0.098 | 5 Hydroxytryptamine uptake inhibitor | 0.098 0.027 DB00977 0.098 0.027 DBMET00457 | DBMET00457 | |
| 0.081 | 0.015 | 0.087 | Heme oxygenase stimulant | 0.087 0.011 DB00977 0.087 0.011 DBMET00457 | DBMET00457 | |
| 0.105 | 0.039 | 0.112 | Bile acid receptor antagonist | 0.112 0.028 DB00977 0.112 0.028 DBMET00457 | DBMET00457 | |
| 0.069 | 0.005 | 0.143 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.143 0.003 DB00977 0.143 0.003 DBMET00457 | DBMET00457 | |
| 0.068 | 0.006 | 0.106 | 5-Alpha-reductase 1 inhibitor | 0.106 0.004 DB00977 0.106 0.004 DBMET00457 | DBMET00457 | |
| 0.075 | 0.016 | 0.078 | Acetylcholine M2 receptor agonist | 0.078 0.014 DB00977 0.078 0.014 DBMET00457 | DBMET00457 | |
| 0.112 | 0.053 | 0.112 | Toll-Like receptor 4 antagonist | 0.112 0.052 DB00977 0.112 0.052 DBMET00457 | ||
| 0.123 | 0.064 | 0.155 | Acetylcholine muscarinic antagonist | 0.155 0.041 DB00977 0.155 0.041 DBMET00457 | DBMET00457 | |
| 0.08 | 0.021 | 0.085 | GABA A receptor antagonist | 0.085 0.02 DB00977 0.085 0.02 DBMET00457 | DBMET00457 | |
| 0.079 | 0.022 | 0.086 | GABA receptor antagonist | 0.086 0.019 DB00977 0.086 0.019 DBMET00457 | DBMET00457 | |
| 0.095 | 0.039 | 0.095 | Alpha 2a adrenoreceptor antagonist | 0.089 0.042 DB00977 0.089 0.042 DBMET00457 | ||
| 0.061 | 0.007 | 0.067 | Glucose-6-phosphate dehydrogenase inhibitor | 0.067 0.005 DB00977 0.067 0.005 DBMET00457 | DBMET00457 | |
| 0.058 | 0.004 | 0.081 | Estrogen-related receptor beta antagonist | 0.081 0.003 DB00977 0.081 0.003 DBMET00457 | DBMET00457 | |
| 0.175 | 0.124 | 0.175 | ErbB-1 antagonist | 0.168 0.137 DB00977 0.168 0.137 DBMET00457 | ||
| 0.053 | 0.003 | 0.065 | Corticosteroid-like | 0.065 0.002 DB00977 0.065 0.002 DBMET00457 | DBMET00457 | |
| 0.098 | 0.049 | 0.098 | Alpha 2 adrenoreceptor antagonist | 0.085 0.06 DB00977 0.085 0.06 DBMET00457 | ||
| 0.093 | 0.044 | 0.097 | Inducible nitric-oxide synthase inhibitor | 0.097 0.04 DB00977 0.097 0.04 DBMET00457 | DBMET00457 | |
| 0.076 | 0.027 | 0.08 | Dopamine uptake inhibitor | 0.08 0.025 DB00977 0.08 0.025 DBMET00457 | DBMET00457 | |
| 0.095 | 0.05 | 0.11 | Ornithine decarboxylase inhibitor | 0.11 0.034 DB00977 0.11 0.034 DBMET00457 | DBMET00457 | |
| 0.116 | 0.071 | 0.145 | DNA polymerase I inhibitor | 0.145 0.052 DB00977 0.145 0.052 DBMET00457 | DBMET00457 | |
| 0.091 | 0.047 | 0.091 | GABA A receptor agonist | 0.087 0.051 DB00977 0.087 0.051 DBMET00457 | ||
| 0.054 | 0.013 | 0.058 | GABA uptake inhibitor | 0.058 0.011 DB00977 0.058 0.011 DBMET00457 | DBMET00457 | |
| 0.133 | 0.094 | 0.159 | Adenylate cyclase stimulant | 0.159 0.049 DB00977 0.159 0.049 DBMET00457 | DBMET00457 | |
| 0.086 | 0.05 | 0.127 | Opioid kappa receptor antagonist | 0.127 0.021 DB00977 0.127 0.021 DBMET00457 | DBMET00457 | |
| 0.037 | 0.005 | 0.037 | Hedgehog signaling activator | 0.03 0.012 DB00977 0.03 0.012 DBMET00457 | ||
| 0.039 | 0.008 | 0.087 | 5-Alpha-reductase 2 inhibitor | 0.087 0.005 DB00977 0.087 0.005 DBMET00457 | DBMET00457 | |
| 0.035 | 0.004 | 0.037 | Progesterone receptor B antagonist | 0.037 0.004 DB00977 0.037 0.004 DBMET00457 | DBMET00457 | |
| 0.097 | 0.077 | 0.097 | Alpha 2b adrenoreceptor antagonist | |||
| 0.053 | 0.034 | 0.053 | Alpha 1L adrenoreceptor antagonist | |||
| 0.078 | 0.059 | 0.086 | Antineoplastic antibiotic | 0.086 0.053 DB00977 0.086 0.053 DBMET00457 | DBMET00457 | |
| 0.087 | 0.07 | 0.09 | ABCA1 expression enhancer | 0.09 0.066 DB00977 0.09 0.066 DBMET00457 | DBMET00457 | |
| 0.057 | 0.04 | 0.057 | Pregnane X receptor antagonist | 0.053 0.05 DB00977 0.053 0.05 DBMET00457 | ||
| 0.114 | 0.099 | 0.12 | Protein kinase stimulant | 0.12 0.092 DB00977 0.12 0.092 DBMET00457 | DBMET00457 | |
| 0.021 | 0.006 | 0.026 | Vitamin D receptor agonist | 0.026 0.004 DB00977 0.026 0.004 DBMET00457 | DBMET00457 | |
| 0.034 | 0.021 | 0.039 | Estrogen-related receptor alpha antagonist | 0.039 0.018 DB00977 0.039 0.018 DBMET00457 | DBMET00457 | |
| 0.142 | 0.13 | 0.142 | Antimitotic | |||
| 0.061 | 0.049 | 0.074 | Dopamine D1 antagonist | 0.074 0.037 DB00977 0.074 0.037 DBMET00457 | DBMET00457 | |
| 0.02 | 0.008 | 0.032 | Thyroid hormone alpha antagonist | 0.032 0.005 DB00977 0.032 0.005 DBMET00457 | DBMET00457 | |
| 0.013 | 0.002 | 0.036 | Transcortin receptor antagonist | 0.036 0.001 DB00977 0.036 0.001 DBMET00457 | DBMET00457 | |
| 0.149 | 0.138 | 0.157 | Hypolipemic | 0.157 0.129 DB00977 0.157 0.129 DBMET00457 | DBMET00457 | |
| 0.167 | 0.157 | 0.187 | 5 Hydroxytryptamine release stimulant | 0.187 0.134 DB00977 0.187 0.134 DBMET00457 | DBMET00457 | |
| 0.044 | 0.034 | 0.044 | Parathyroid hormone antagonist | 0.043 0.036 DB00977 0.043 0.036 DBMET00457 | ||
| 0.162 | 0.153 | 0.176 | Spasmolytic | 0.176 0.14 DB00977 0.176 0.14 DBMET00457 | DBMET00457 | |
| 0.105 | 0.096 | 0.105 | Cyclooxygenase 3 inhibitor | |||
| 0.118 | 0.111 | 0.118 | Cholinergic | |||
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.011 | 0.011 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.008 DB00977 0.012 0.008 DBMET00457 | DBMET00457 | |
| 0.03 | 0.031 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DB00977 0.042 0.017 DBMET00457 | DBMET00457 | |
| 0.018 | 0.027 | 0.024 | Dopamine D1 agonist | 0.024 0.014 DB00977 0.024 0.014 DBMET00457 | DBMET00457 | |
| 0.011 | 0.02 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DB00977 0.014 0.013 DBMET00457 | DBMET00457 | |
| 0.063 | 0.073 | 0.069 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 DB00977 0.069 0.063 DBMET00457 | DBMET00457 | |
| 0.185 | 0.198 | 0.204 | Antithrombotic | 0.204 0.172 DB00977 0.204 0.172 DBMET00457 | DBMET00457 | |
| 0.116 | 0.14 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.107 DB00977 0.122 0.107 DBMET00457 | DBMET00457 | |
| 0.187 | 0.213 | 0.243 | Interleukin 2 agonist | 0.243 0.127 DB00977 0.243 0.127 DBMET00457 | DBMET00457 | |
| 0.125 | 0.152 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.102 DB00977 0.133 0.102 DBMET00457 | DBMET00457 | |
| 0.072 | 0.1 | 0.089 | Topoisomerase I inhibitor | 0.089 0.08 DB00977 0.089 0.08 DBMET00457 | DBMET00457 | |
| 0.04 | 0.073 | 0.061 | Acetylcholine M3 receptor antagonist | 0.061 0.04 DB00977 0.061 0.04 DBMET00457 | DBMET00457 | |
| 0.018 | 0.056 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.024 DB00977 0.035 0.024 DBMET00457 | DBMET00457 | |
| 0.153 | 0.192 | 0.18 | RNA-directed DNA polymerase inhibitor | 0.18 0.133 DB00977 0.18 0.133 DBMET00457 | DBMET00457 | |
| 0.023 | 0.073 | 0.054 | Dopamine D5 agonist | 0.054 0.015 DB00977 0.054 0.015 DBMET00457 | DBMET00457 | |
| 0.059 | 0.109 | 0.097 | Opioid antagonist | 0.097 0.05 DB00977 0.097 0.05 DBMET00457 | DBMET00457 | |
| 0.071 | 0.124 | 0.118 | Adenylate cyclase inhibitor | 0.118 0.069 DB00977 0.118 0.069 DBMET00457 | DBMET00457 | |
| 0.038 | 0.092 | 0.077 | Opioid mu receptor antagonist | 0.077 0.041 DB00977 0.077 0.041 DBMET00457 | DBMET00457 | |
| 0.122 | 0.188 | 0.153 | Free radical scavenger | 0.153 0.141 DB00977 0.153 0.141 DBMET00457 | DBMET00457 | |
| 0.116 | 0.197 | 0.149 | Phospholipase C inhibitor | 0.149 0.107 DB00977 0.149 0.107 DBMET00457 | DBMET00457 | |
| 0.036 | 0.171 | 0.083 | NMDA receptor antagonist | 0.083 0.062 DB00977 0.083 0.062 DBMET00457 | DBMET00457 | |
| 0.018 | 0.163 | 0.066 | NMDA 2 receptor antagonist | 0.066 0.055 DB00977 0.066 0.055 DBMET00457 | DBMET00457 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |